Trexquant Investment LP Y M Abs Therapeutics, Inc. Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$4.88 - $7.42 $234,088 - $355,929	-47,969 Reduced 62.63%	28,616 $195,000
Q3 2023 Nov 13, 2023	BUY	$4.86 - $7.23 $300,275 - $446,705	61,785 Added 417.47%	76,585 $417,000
Q2 2023 Aug 11, 2023	BUY	$5.68 - $10.34 $84,064 - $153,032	14,800 New	14,800 $100,000
Q3 2022 Nov 14, 2022	BUY	$13.96 - $19.67 $222,131 - $312,989	15,912 New	15,912 $229,000
Q3 2021 Nov 12, 2021	SELL	$27.47 - $37.31 $238,714 - $324,223	-8,690 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$25.45 - $37.64 $21,683 - $32,069	-852 Reduced 8.93%	8,690 $294,000
Q1 2021 May 13, 2021	BUY	$29.16 - $51.96 $278,244 - $495,802	9,542 New	9,542 $289,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.